ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2021

TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma.

Yifan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.